Close menu




Growth

Photo credits: pixabay.com

Commented by Juliane Zielonka on May 24th, 2024 | 07:00 CEST

NVIDIA, Vidac Pharma, Bayer - Opportunities for innovation and growth

  • Pharma
  • Biotechnology
  • Growth
  • AI

The next industrial revolution has begun – companies and countries are working with firms like NVIDIA to transform traditional data centres worth billions of euros into accelerated computing hubs and build a new type of data centre: AI factories to produce artificial intelligence. The areas of application are vast, including data processing, generative AI, pharmaceutical research, weather simulations, robotics and many more. Vidac Pharma, for example, is an exciting candidate in the field of drug research. Their innovative approach in oncology can reverse the function of cancer cells. If successful, Bayer would have less to worry about. The Leverkusen-based company is fighting the wave of US lawsuits in connection with RoundUp®. The glyphosate-based herbicide is suspected of causing cancer. Bayer is now pursuing a new strategy in the face of the six-figure lawsuits. Where do investors find the best innovations and greatest growth opportunities?

Read

Commented by Stefan Feulner on September 6th, 2023 | 07:30 CEST

Cannabis stocks showing signs of life - Aurora Cannabis, Cantourage Group, Canopy Growth

  • Cannabis
  • Growth

In recent years, the once-hyped cannabis industry was considered a true capital destroyer. Even market leaders like Aurora Cannabis, Tilray, or Canopy Growth saw their stock values plummet by more than 90% at their peak. A letter from the US Department of Health and Human Services has sparked the first signs of a potential revival, which could eventually lead to a sustainable bottoming out in the long run.

Read

Commented by Nico Popp on January 26th, 2023 | 20:07 CET

Gold and war - rethink now! Barrick Gold, Globex Mining, Rheinmetall

  • Mining
  • Gold
  • Commodities
  • armaments
  • Growth

Gold is shining again. The weaker dollar and the existing geopolitical risks are boosting the precious metal. But how should investors invest? What opportunities are there off the beaten track? And: Given the crises, does gold have to be in the portfolio? We highlight three hot stocks and provide insights and outlooks on the gold price and the overall geopolitical situation.

Read

Commented by Armin Schulz on January 2nd, 2023 | 08:07 CET

Amazon, Aspermont, TeamViewer - Which stock will take off fastest in 2023?

  • Digitization
  • Fintech
  • Growth

The COVID-19 pandemic has dramatically impacted the global economy, and investors have had to consider a host of new risks and opportunities. One phenomenon that has emerged from the crisis is a shift in demand toward digital business models. Digital companies were already present in the market before the pandemic, but their growth has gone through the roof since the pandemic. With the endemic in 2022, growth has often slowed. We take a look at three companies that could bounce back in 2023.

Read

Commented by Juliane Zielonka on December 29th, 2022 | 09:27 CET

Aspermont, Amazon, flatexDEGIRO - In the frenzy of customer growth

  • Growth
  • Digitization
  • Investments

Aspermont, Amazon and flatexDEGIRO combine rapid customer growth in digital times. As a digital publishing pioneer, Aspermont is a frontrunner for high-quality content in the mining, energy and agriculture sectors. Financials from the fiscal year 2022 prove it. According to insiders, Amazon is trying its hand at its own sports app. The Company recently suffered a defeat in the battle for streaming rights. Big tech giant google secured a lucrative NFL package. Likewise, flatex has secured the user accounts of DEGIRO. Since 2019 and now after the merger, the listed broker has recorded customer growth of 500%. That also makes BaFin sit up and take notice.

Read

Commented by Armin Schulz on December 12th, 2022 | 10:20 CET

BioNTech, va-Q-tec, Cardiol Therapeutics, Ambrx Biopharma - Biotech second-line stocks explode

  • Biotechnology
  • Growth
  • Investments

For investors in biotech stocks, 2022 was often a year to forget. After the Corona hype, the market clouded over significantly, in part due to rising interest rates. December is the time of year when investors can make adjustments to their portfolio, thereby reducing their tax burden for the year ahead. This year is no exception, yet three stocks shot up last Friday. That is unusual during tax loss season. We look at the three high flyers and BioNTech, a big player in the biotech sector.

Read

Commented by Stefan Feulner on September 19th, 2022 | 11:12 CEST

Nordex, Aspermont, TeamViewer AG - New opportunities for growth stocks

  • Technology
  • Growth
  • Investments

The skies for growth stocks have clouded over considerably since the beginning of the year with the change in strategy by the central banks. With all their might, the monetary guardians want to curb rampant inflation with several interest rate hikes. This week, the Fed is expected to make a third major interest rate hike, with experts predicting a rise of 100 basis points. However, whether further interest rate steps will follow is likely to be at least questioned. If the fight against inflation continues to be played as a trump card for the re-election of the current government until the midterm elections in the US, a change of strategy is likely to be made afterwards at the latest in order not to bring the economy to a complete standstill. The result would be a bullish stock market, with growth stocks in particular likely to benefit significantly.

Read

Commented by Nico Popp on September 14th, 2022 | 12:23 CEST

End of capitalism? Here comes growth! Mercedes-Benz, BrainChip, Amazon

  • Growth
  • Technology
  • Innovations
  • chips

These days, the book The End of Capitalism by TAZ journalist Ulrike Herrmann is causing quite a stir. Its basic tenor is that the growth story is coming to an end. In order to achieve climate targets, it is now a matter of shrinking in the right way. Even if many readers might have spontaneously rolled their eyes at both the title and Ms Herrmann's employer, it is worth taking a closer look. Here is why the growth of the future offers opportunities.

Read

Commented by Nico Popp on August 30th, 2022 | 13:40 CEST

A look at how growth stocks are doing: NEL, Pathfinder Ventures, Deutsche Bank

  • Growth
  • Camping
  • Investments

Now that the Fed has made it unmistakably clear that fighting inflation is a top priority, investors are asking what this means for their portfolios. Although popular opinion does not see much prospect for growth stocks in times of rising interest rates, it is worth looking at the details. What matters, in the end, is how robust business models are. Then financing solutions can also be found for growth stocks.

Read

Commented by Nico Popp on February 12th, 2021 | 13:41 CET

Baidu, wallstreet:online, Alibaba: New Business, Great Potential

  • Growth

When companies move into new business areas, it quickly justifies a revaluation. The better the new activities complement the existing business, the greater the share price potential. A quick check of three stocks that could soon be valued very differently: Baidu, wallstreet:online and Alibaba.

Read